Nicomorphine
| Clinical data | |
|---|---|
| Other names | Morphine dinicotinate, 3,6-dinicotinoylmorphine |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral, Intravenous, Rectal |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.326 |
| Chemical and physical data | |
| Formula | C29H25N3O5 |
| Molar mass | 495.535 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Nicomorphine (Vilan, Subellan, Gevilan, MorZet) is the 3,6-dinicotinate ester of morphine. It is a strong opioid agonist analgesic two to three times as potent as morphine with a side effect profile similar to that of dihydromorphine, morphine, and diamorphine.
Nicomorphine was first synthesized in 1904 and was patented as Vilan by Lannacher Heilmittel G.m.b.H. of Austria in 1957.